Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating deep repetitive transcranial magnetic stimulation of the precuneus for Alzheimer's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease | Phase 1, Phase 2 | Status: RECRUITING